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A 51-year-old woman with diabetes and end-stage renal fail-
ure, on dialysis, was treated with deferoxamine for iron over-
load resulting from repeated blood transfusion. Two weeks 
aft er starting treatment, she presented with progressive swell-
ing of the left  orbital with exophthalmos, nodules on her nose, 
and low-grade fever.
On examination, she had coalescent nodules with yellowish, 
mucus-like discharge and local tenderness on palpation (Fig-
ure 1). Magnetic resonance imaging disclosed a mass invading 
the paranasal sinus, and penetrating the nasal fl oor and hard 
palate (Figure 2). Mucormycosis was identifi ed from the pus 
culture (Figure 3). Despite aggressive treatment with surgical 
débridement and intravenous amphotericin B, she died from 
septic shock and respiratory failure.
Mucormycosis usually presents with rhino-orbito-cerebral, 
pulmonary, disseminated, cutaneous, or gastrointestinal 
involvement. Immunocompromised states such as diabetes 
mellitus, end-stage renal disease, and deferoxamine therapy pre-
dispose patients to infection. Deferoxamine-related mucormy-
cosis has a very high mortality (reported to be around 89%) in 
dialysis patients.
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Figure 1 | Photograph of the patient, showing 
swelling and erythematous skin lesions on 
the left forehead and periorbital areas and 
two nodules measuring 3 × 1 cm and 2 × 1 cm 
on the nasal ridge, with local tenderness and 
fragile bony structure on palpation.
Figure 2 | Gadolinium-enhanced T1-weighted 
magnetic resonance brain imaging. 
(a) Mucormycosis with invasion into the 
paranasal sinus; the mucosa of the left maxillary 
sinus was thickening, and bone destruction 
of the nasal bone, hard palate, and paranasal 
sinuses was observed (arrow). (b) Extension of 
mucous debris to the nasal cartilage, nasal floor, 
and hard palate (arrow).
Figure 3 | Mucormycosis was identified from 
the pus culture (arrows). (Hematoxylin and 
eosin stain; original magnification, ×200.)
